Prediction of binding affinities between the human amphiphysin-1 SH3 domain and its peptide ligands using homology modeling, molecular dynamics and molecular field analysis.
about
Identification and rational redesign of peptide ligands to CRIP1, a novel biomarker for cancersModeling protein-peptide recognition based on classical quantitative structure-affinity relationship approach: implication for proteome-wide inference of peptide-mediated interactions.HomoSAR: bridging comparative protein modeling with quantitative structural activity relationship to design new peptides.Characterization of domain-peptide interaction interface: prediction of SH3 domain-mediated protein-protein interaction network in yeast by generic structure-based models.Transient protein-protein interaction of the SH3-peptide complex via closely located multiple binding sites.Structure-based characterization of the binding of peptide to the human endophilin-1 Src homology 3 domain using position-dependent noncovalent potential analysis.Exploring the activity space of peptides binding to diverse SH3 domains using principal property descriptors derived from amino acid rotamers.Mutatomics analysis of the systematic thermostability profile of Bacillus subtilis lipase A.Artificial neural network models for prediction of intestinal permeability of oligopeptides.Computational study on the molecular mechanisms of drug resistance of Narlaprevir due to V36M, R155K, V36M+R155K, T54A, and A156T mutations of HCV NS3/4A protease.An index for characterization of natural and non-natural amino acids for peptidomimeticsPrediction of peptides binding to the PKA RIIalpha subunit using a hierarchical strategyBinding mode analyses of NAP derivatives as mu opioid receptor selective ligands through docking studies and molecular dynamics simulation.Computational insights into the selectivity mechanism of APP-IP over matrix metalloproteinases.The molecular mechanism studies of chirality effect of PHA-739358 on Aurora kinase A by molecular dynamics simulation and free energy calculations.Rational Molecular Design of Potent PLK1 PBD Domain-binding Phosphopeptides Using Preferential Amino Acid Building Blocks.Molecular modeling study on the drug resistance mechanism of NS5B polymerase to TMC647055.Computational study on the drug resistance mechanism of HCV NS3 protease to BMS-605339.Rational design of angiotensin-I-converting enzyme inhibitory peptides by integrating in silico modeling and an in vitro assay.Stepwise identification of HLA-A*0201-restricted CD8+ T-cell epitope peptides from herpes simplex virus type 1 genome boosted by a StepRank scheme.Molecular dynamics study of segment peptides of Bax, Bim, and Mcl-1 BH3 domain of the apoptosis-regulating proteins bound to the anti-apoptotic Mcl-1 protein.Studying the mechanism that enables paullones to selectively inhibit glycogen synthase kinase 3 rather than cyclin-dependent kinase 5 by molecular dynamics simulations and free-energy calculations.Computer-aided design of amino acid-based therapeutics: a review.Exploring the binding mechanisms of diaminopimelic acid analogs to meso-diaminopimelate dehydrogenase by molecular modeling
P2860
Q24318965-90A9F986-D618-454E-B495-C32114B6656AQ30009536-F429E955-E169-41A2-912A-C92766AA4198Q30009545-4BB41D8F-D097-4816-AEEE-6DEADF1902DCQ30010144-F9902275-35C2-42B0-B993-9A6164072607Q30010150-0AD6B3BB-96E6-4C91-9420-F1EAAFBE292FQ30010234-537119DE-86FD-428E-94A5-F31359FB293AQ30156076-EBE25E47-E6A2-4B8C-B4A2-652214A605F7Q30362557-452010D1-1171-4C9B-873E-5EA80790D7FBQ33290486-8F83D8AC-31B8-400F-B97C-FF80563CB5B4Q34436352-34BC3269-41B9-421F-AE1B-D831D40898EAQ34917849-5B0EB0FD-842F-4255-8B04-52C80C19CD2AQ35051913-FD0B2326-2911-4935-9F33-39B31BE4D961Q38743944-612D8954-0700-4CBA-A64F-1C0B75470B63Q39506214-5BB3837B-D3DA-4AF0-95E6-0B1F5C81FCA0Q39794961-087836AA-0E6D-4060-BB0C-EFB66828A711Q40602376-BC113493-3828-46E8-9C94-DC27A29B28D4Q40935601-CE9B6B18-B06D-48A8-8B76-A907EDD77F78Q40962998-70E984F3-F55D-41CF-BC7A-70CC04E06A7CQ43769415-DDFB3A3D-A04B-48D5-AFA5-992AFFF9CD0AQ45371304-DB16CB64-6077-4D64-B7FC-4B482CC30221Q46498508-2D19C9B3-FFFB-4DFB-93B2-B90F424298B1Q54667185-27BCDCDE-EF13-48BE-9202-EC8E4246876AQ55315041-1E254237-E238-4CCB-90D7-B10D64AFA510Q57172776-308124F3-895C-4443-9155-D60E4EC7F886
P2860
Prediction of binding affinities between the human amphiphysin-1 SH3 domain and its peptide ligands using homology modeling, molecular dynamics and molecular field analysis.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Prediction of binding affiniti ...... and molecular field analysis.
@ast
Prediction of binding affiniti ...... and molecular field analysis.
@en
type
label
Prediction of binding affiniti ...... and molecular field analysis.
@ast
Prediction of binding affiniti ...... and molecular field analysis.
@en
prefLabel
Prediction of binding affiniti ...... and molecular field analysis.
@ast
Prediction of binding affiniti ...... and molecular field analysis.
@en
P2093
P356
P1476
Prediction of binding affiniti ...... and molecular field analysis.
@en
P2093
Benzhuo Lu
William McLaughlin
P356
10.1021/PR0502267
P577
2006-01-01T00:00:00Z